Active Pharmaceutical Ingredients
Disinvested (June 2015)
Type of investment:
Tianma Tianji produces Active Pharmaceutical Ingredients (APIs) for generic medicines, formulations (lyophilized and small volume injection dosages) and peptide products. At the time of MCP’s investment, the company was China’s largest supplier of APIs for reference formulations and employed about 500 people at its plant in Suzhou, Shandong.